12

2026

-

05

Colloidal Silicon Dioxide China Supplier

Zhongqi (Shandong) Silicon Materials Co., Ltd. is a leading Chinese manufacturer and supplier of high-quality colloidal silicon dioxide for the global pharmaceutical industry.


Reliable Colloidal Silicon Dioxide Supplier from China

Zhongqi (Shandong) Silicon Materials Co., Ltd. is a leading Chinese manufacturer and supplier of high-quality colloidal silicon dioxide for the global pharmaceutical industry. According to Google Trends data, "Pharmaceutical grade silicon dioxide China" is the fastest-growing search term in China, reflecting the increasing global demand for Chinese pharmaceutical excipients.

Why Choose Us as Your Supplier:

  • Manufacturing Expertise: Years of specialized experience in colloidal silica production
  • Advanced Technology: State-of-the-art production facilities and process control systems
  • Comprehensive Product Range: Complete ZLXIDE™ series covering all standard grades
  • Consistent Quality: Strict GMP compliance and rigorous quality control
  • Competitive Pricing: Cost-effective solutions without compromising quality
  • Reliable Supply: Large production capacity ensuring stable delivery
  • Global Logistics: Efficient shipping to destinations worldwide
  • Technical Support: Professional team providing formulation assistance

Our ZLXIDE™ Colloidal Silicon Dioxide Range:

  • ZLXIDE™ 150: Specific surface area 150 m²/g
  • ZLXIDE™ 200: Standard grade, 200 m²/g (most popular)
  • ZLXIDE™ 300: High surface area, 300 m²/g
  • ZLXIDE™ 380: Ultra-high surface area, 380 m²/g
  • ZLXIDE™ R Series: Hydrophobic modified grades

Regulatory Support:

We provide comprehensive regulatory documentation including Certificates of Analysis, Material Safety Data Sheets (MSDS), and Drug Master Files (DMFs) to support our customers' regulatory submissions in various countries.

Global Customer Base:

Our colloidal silicon dioxide products are exported to over 30 countries and regions worldwide, serving pharmaceutical manufacturers of all sizes from multinational corporations to local specialty drug producers.